Home > Boards > US Listed > Medical - Drugs > Relmada Therapeutics Inc. (RLMD)

From the recent quarterly filing

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Biobonic Member Profile
 
Followed By 10
Posts 685
Boards Moderated 0
Alias Born 07/03/19
160x600 placeholder
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/5/2021 4:09:28 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 3/31/2021 5:02:19 PM
Relmada Therapeutics EPS misses by $0.25 Seeking Alpha - 3/23/2021 4:31:48 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/15/2021 5:17:15 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 3/15/2021 5:14:39 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/11/2021 5:52:09 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/11/2021 5:51:14 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/10/2021 6:19:12 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/2/2021 4:08:47 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/26/2021 5:07:46 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/26/2021 4:59:15 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/26/2021 4:55:50 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/17/2021 6:38:00 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/16/2021 5:19:38 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/16/2021 5:19:24 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/16/2021 4:52:26 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/16/2021 4:22:22 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/16/2021 4:16:38 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/12/2021 9:39:36 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/12/2021 8:06:59 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/4/2021 5:42:48 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/4/2021 5:40:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/3/2021 6:35:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 2/2/2021 5:06:29 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 2/2/2021 3:15:45 PM
Biobonic   Monday, 11/09/20 08:00:00 PM
Re: None
Post # of 500 
From the recent quarterly filing

Quote:
On July 15, 2020, an employee of the Company filed a Complaint alleging unequal pay based on gender and other employment based claims. The Company intends to defend the lawsuit vigorously and does not expect that the lawsuit will have a material effect on its financial position.



I wonder who?

Quote:
NEW YORK, March 24, 2020 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced the appointment of Judy Caron, Ph.D., as Vice President of Drug Development.



On the website 'meet our team' Dr Caron is not featured... nor is the VP of Drug Development position featured

Not drawing any conclusions.


Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences